Loss-of-function mutations in the gene encoding filaggrin (FLG) are present in up to 50% of patients with moderate-to-severe AD9, 10 and have been shown to increase the risk of inhalant allergic sensitization, allergic rhinitis, asthma,11, 12 and peanut allergy.13 This evidence concerns the gene FLG and allergic rhinitis.